BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//CMS QIN-QIO - ECPv6.15.20//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:CMS QIN-QIO
X-ORIGINAL-URL:https://qi.ipro.org
X-WR-CALDESC:Events for CMS QIN-QIO
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20230312T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20231105T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20240310T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20241103T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20250309T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20251102T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20240209T120000
DTEND;TZID=America/New_York:20240209T130000
DTSTAMP:20260428T170300
CREATED:20230831T191952Z
LAST-MODIFIED:20230831T194339Z
UID:36425-1707480000-1707483600@qi.ipro.org
SUMMARY:Ensuring Medication for Opioid Use Disorder (MOUD) Treatment through the Care Continuum Webinar Series Session 5
DESCRIPTION:More than 1 million Medicare beneficiaries had a diagnosis of opioid use disorder (OUD) in 2020.\nHowever\, fewer than one in five received medication to treat this condition. In addition\, the number of patients who stay in treatment after hospital discharge decrease drastically. \nThis webinar series is a collaboration between all Quality Innovation Network-Quality Improvement Organizations and will provide strategies\, interventions\, and targeted solutions to ensure access to MOUD treatment and facilitate continuity of care through the continuum. \nSession 5: Management of Patients on MOUD During the Nursing Home Stay Part 1 \nIn this session\, we will discuss admissions assessment & treatment\, addressing stigma\, and naloxone training.
URL:https://qi.ipro.org/upcoming-events/ensuring-medication-for-opioid-use-disorder-moud-treatment-through-the-care-continuum-webinar-series-session-5/
LOCATION:Online via WebEx
CATEGORIES:Free event,Opioid
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20240308T120000
DTEND;TZID=America/New_York:20240308T130000
DTSTAMP:20260428T170300
CREATED:20230831T192231Z
LAST-MODIFIED:20230831T194434Z
UID:36427-1709899200-1709902800@qi.ipro.org
SUMMARY:Ensuring Medication for Opioid Use Disorder (MOUD) Treatment through the Care Continuum Webinar Series Session 6
DESCRIPTION:More than 1 million Medicare beneficiaries had a diagnosis of opioid use disorder (OUD) in 2020.\nHowever\, fewer than one in five received medication to treat this condition. In addition\, the number of patients who stay in treatment after hospital discharge decrease drastically. \nThis webinar series is a collaboration between all Quality Innovation Network-Quality Improvement Organizations and will provide strategies\, interventions\, and targeted solutions to ensure access to MOUD treatment and facilitate continuity of care through the continuum. \nSession 1: Management of Patients on MOUD During the Nursing Home Stay Part 2  \nIn this session\, we will discuss admissions assessment & treatment\, addressing stigma\, and naloxone training.
URL:https://qi.ipro.org/upcoming-events/ensuring-medication-for-opioid-use-disorder-moud-treatment-through-the-care-continuum-webinar-series-session-6/
LOCATION:Online via WebEx
CATEGORIES:Free event,Opioid
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20240412T120000
DTEND;TZID=America/New_York:20240412T130000
DTSTAMP:20260428T170300
CREATED:20230831T192628Z
LAST-MODIFIED:20230831T194522Z
UID:36430-1712923200-1712926800@qi.ipro.org
SUMMARY:Ensuring Medication for Opioid Use Disorder (MOUD) Treatment through the Care Continuum Webinar Series Session 7
DESCRIPTION:More than 1 million Medicare beneficiaries had a diagnosis of opioid use disorder (OUD) in 2020.\nHowever\, fewer than one in five received medication to treat this condition. In addition\, the number of patients who stay in treatment after hospital discharge decrease drastically. \nThis webinar series is a collaboration between all Quality Innovation Network-Quality Improvement Organizations and will provide strategies\, interventions\, and targeted solutions to ensure access to MOUD treatment and facilitate continuity of care through the continuum. \nSession 7: Sustaining Recovery for Patients on MOUD Part 1  \nIn this session\, we will discuss Alternatives to Opioids (ALTO)\, peer support\, narcotics anonymous meetings\, counseling\, and use of technologies.
URL:https://qi.ipro.org/upcoming-events/ensuring-medication-for-opioid-use-disorder-moud-treatment-through-the-care-continuum-webinar-series-session-7/
LOCATION:Online via WebEx
CATEGORIES:Free event,Opioid
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20240510T120000
DTEND;TZID=America/New_York:20240510T130000
DTSTAMP:20260428T170300
CREATED:20230831T192840Z
LAST-MODIFIED:20230831T194544Z
UID:36432-1715342400-1715346000@qi.ipro.org
SUMMARY:Ensuring Medication for Opioid Use Disorder (MOUD) Treatment through the Care Continuum Webinar Series Session 8
DESCRIPTION:More than 1 million Medicare beneficiaries had a diagnosis of opioid use disorder (OUD) in 2020.\nHowever\, fewer than one in five received medication to treat this condition. In addition\, the number of patients who stay in treatment after hospital discharge decrease drastically. \nThis webinar series is a collaboration between all Quality Innovation Network-Quality Improvement Organizations and will provide strategies\, interventions\, and targeted solutions to ensure access to MOUD treatment and facilitate continuity of care through the continuum. \nSession 8: Sustaining Recovery for Patients on MOUD Part 2  \nIn this session\, we will discuss Alternatives to Opioids (ALTO)\, peer support\, narcotics anonymous meetings\, counseling\, and use of technologies.
URL:https://qi.ipro.org/upcoming-events/ensuring-medication-for-opioid-use-disorder-moud-treatment-through-the-care-continuum-webinar-series-session-8/
LOCATION:Online via WebEx
CATEGORIES:Free event,Opioid
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20240607T120000
DTEND;TZID=America/New_York:20240607T130000
DTSTAMP:20260428T170300
CREATED:20230831T193028Z
LAST-MODIFIED:20230831T194613Z
UID:36434-1717761600-1717765200@qi.ipro.org
SUMMARY:Ensuring Medication for Opioid Use Disorder (MOUD) Treatment through the Care Continuum Webinar Series Session 9
DESCRIPTION:More than 1 million Medicare beneficiaries had a diagnosis of opioid use disorder (OUD) in 2020.\nHowever\, fewer than one in five received medication to treat this condition. In addition\, the number of patients who stay in treatment after hospital discharge decrease drastically. \nThis webinar series is a collaboration between all Quality Innovation Network-Quality Improvement Organizations and will provide strategies\, interventions\, and targeted solutions to ensure access to MOUD treatment and facilitate continuity of care through the continuum. \nSession 9: Management of Patients on MOUD: Key Takeaways and Series Wrap Up \nIn this session\, a general certificate of attendance will be provided for continuing education/contact hours. Attendees are responsible for determining if this program meets the criteria for licensure or recertification for their discipline.
URL:https://qi.ipro.org/upcoming-events/ensuring-medication-for-opioid-use-disorder-moud-treatment-through-the-care-continuum-webinar-series-session-9/
LOCATION:Online via WebEx
CATEGORIES:Free event,Opioid
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20241009T150000
DTEND;TZID=America/New_York:20241009T160000
DTSTAMP:20260428T170300
CREATED:20240912T125743Z
LAST-MODIFIED:20240912T125743Z
UID:38144-1728486000-1728489600@qi.ipro.org
SUMMARY:IPRO QIN-QIO Presents: A Pathway to Transforming Patient Care through a Pain and Opioid Learning Health System (LHS) Collaborative (POLLC)
DESCRIPTION:Wednesday\, October 9 from 3 to 4 pm ET\nRegistration Link: https://bit.ly/47jRmnm\nLearning Objectives\nIn this webinar\, we will: \n\nDefine the characteristics and benefits of a Learning Health System\nDescribe foundational POLLC activities to support Learning Health Systems aimed at advancing evidence driven pain and opioid management and improving patient outcomes\nProvide a Round Table on lessons learned from POLLC participants\nEnable participants to design their LHS leveraging POLLC tools and resources\n\nAudience\nThis activity is appropriate for all those interested in improving pain and opioid management and outcomes\, and/or improving Learning Health Systems for other conditions. This includes: \n\nClinicians (e.g.\, Physicians\, NPs\, PAs\, Nurses\, Pharmacists)\, Public Health Professionals\, Patients and/or Care Partners\nHealth Systems\, Hospitals\, Primary Care\, Specialty Clinics\, Nursing Homes\, and Health IT vendors\n\nSpeakers\nJerry Osheroff\, MD – Principal\, TMIT Consulting\, LLC\nDr. Jerry Osheroff is a primary care physician by training who has focused for over 30 years on developing and implementing approaches to improve healthcare delivery processes and outcomes. He is a principal of TMIT Consulting\, LLC and a care transformation subject matter expert helping VA become a learning health system and achieve the quintuple aim. He is the lead author on influential guidebooks and national roadmaps for achieving these goals and brings together diverse stakeholders to implement the recommendations (e.g.\, via initiatives such as POLLC and ACT) and accelerate improvements in care delivery and results. \nAnne Myrka\, RPh\, MAT\, CPHQ – Senior Director of Drug Safety ad Chronic Disease Management\, IPRO\nAnne Myrka earned a Bachelor of Science in Pharmacy from Albany College of Pharmacy and Health Sciences and a Master of Arts in Teaching Science from the State University at New Paltz. She is a licensed pharmacist in New York and Vermont. She has presented nationally about high-risk medication management\, care transitions\, and medication reconciliation\, and has co-authored multiple peer-reviewed journal articles on these topics. \nLynn Wilson\, MS – Senior Quality Improvement Specialist\, IPRO\nLynn Wilson has more than 30 years of experience with regulatory agencies for community mental health centers and nursing homes and is a nationally recognized QI leader in long-term care\, behavioral health and hospice and palliative care settings. Under her leadership\, behavioral health and end of-life care practice innovations generated through frontline staff quality improvement processes have been recognized as national best practices.
URL:https://qi.ipro.org/upcoming-events/ipro-qin-qio-presents-a-pathway-to-transforming-patient-care-through-a-pain-and-opioid-learning-health-system-lhs-collaborative-pollc/
LOCATION:Online via WebEx
CATEGORIES:Free event,Opioid
END:VEVENT
END:VCALENDAR